Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope (2023)
https://pubmed.ncbi.nlm.nih.gov/37197377/

Diagnostic delay is associated with Uveitis and Inflammatory Bowel Disease in Ankylosing Spondylitis: a multi-centre cohort study of extra-musculoskeletal manifestations in Spondyloarthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/37184889/

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update (2023)
https://pubmed.ncbi.nlm.nih.gov/36270658/

Depression and anxiety in a real-world psoriatic arthritis longitudinal study: should we focus more on patients’ perception? (2023)
https://pubmed.ncbi.nlm.nih.gov/35819812/

The association between comorbidities and disease activity in spondyloarthritis – A narrative review (2023)
https://pubmed.ncbi.nlm.nih.gov/37541813/

Advances in Psoriatic Arthritis Six Decades On (2023)
https://pubmed.ncbi.nlm.nih.gov/37640613/

Association between psoriatic disease and lifestyle factors and comorbidities: cross-sectional analysis and Mendelian randomization (2022)
https://pubmed.ncbi.nlm.nih.gov/35861400/

Separating the effects of childhood and adult body size on inflammatory arthritis: a Mendelian randomisation study (2022)
https://pubmed.ncbi.nlm.nih.gov/35995490/

Association between individual and country-level socioeconomic factors and work participation in spondyloarthritis including psoriatic arthritis: Analysis of the ASAS-perSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/34153894/

Individual and country-level socioeconomic factors and health outcomes in spondyloarthritis: analysis of the ASAS perSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/34387300/

Depression and anxiety symptoms at TNF inhibitor initiation are associated with impaired treatment response in axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/33713118/

Similar biologic drug response regardless of radiographic status in axial spondyloarthritis: data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis registry (2021)
https://pubmed.ncbi.nlm.nih.gov/33502476/

Comorbidity and response to TNF inhibitors in axial spondyloarthritis: longitudinal analysis of the BSRBR-AS (2021)
https://pubmed.ncbi.nlm.nih.gov/33369676/

Diagnostic delay in axial spondyloarthritis: a systematic review and meta-analysis (2021)
https://pubmed.ncbi.nlm.nih.gov/33428758/

Association between comorbidities and disease activity in axial spondyloarthritis: results from the BSRBR-AS (2021)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516505/

Comorbidities in psoriatic arthritis: a systematic review and meta-analysis (2021)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835184/

Diagnosis of spinal tuberculosis in an Asian patient with unexplained chronic back pain (2021)
https://pubmed.ncbi.nlm.nih.gov/34864919/

Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis (2020)
https://pubmed.ncbi.nlm.nih.gov/33053193/

Incorporating natural language processing to improve classification of axial spondyloarthritis using electronic health records (2020)
https://pubmed.ncbi.nlm.nih.gov/31535693/

Systematic review of mental health comorbidities in psoriatic arthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/31486931/

The impact of smoking on response to TNF inhibitors in axial spondyloarthritis: methodological considerations for longitudinal observational studies (2020)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694004/

Smoking in spondyloarthritis: unravelling the complexities (2020)
https://pubmed.ncbi.nlm.nih.gov/32236486/

Prevalence of extra-articular manifestations in psoriatic arthritis: a systematic review and meta-analysis (2020)
https://pubmed.ncbi.nlm.nih.gov/32160297/

Smoking status and cause-specific discontinuation of tumour necrosis factor inhibitors in axial spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/31331375/

Smoking does not protect patients with axial spondyloarthritis from attacks of uveitis (2019)
https://pubmed.ncbi.nlm.nih.gov/31005901/

Comparison of comorbidities and treatment between ankylosing spondylitis and non-radiographic axial spondyloarthritis in the United States (2019)
https://pubmed.ncbi.nlm.nih.gov/31081033/

Comorbidity burden in axial spondyloarthritis: a cluster analysis (2019)
https://pubmed.ncbi.nlm.nih.gov/31220322/

Comment on: Comorbidity burden in axial spondyloarthritis: a cluster analysis: reply (2019)
https://pubmed.ncbi.nlm.nih.gov/31865393/

Associations between smoking and extra-axial manifestations and disease severity in axial spondyloarthritis: results from the BSR Biologics Register for Ankylosing Spondylitis (BSRBR-AS) (2019)
https://pubmed.ncbi.nlm.nih.gov/30561738/

The prevalence of depression in axial spondyloarthritis and its association with disease activity: a systematic review and meta-analysis (2018)
https://pubmed.ncbi.nlm.nih.gov/29996916/

Alcohol and disease activity in axial spondyloarthritis: a cross-sectional study (2018)
https://pubmed.ncbi.nlm.nih.gov/29322342/

Autoantibodies to Osteoprotegerin are Associated with Low Hip Bone Mineral Density and History of Fractures in Axial Spondyloarthritis: A Cross-Sectional Observational Study (2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587630/

Vitamin D Deficiency in Axial Spondyloarthritis is Associated With Higher Disease Activity (2017)
https://pubmed.ncbi.nlm.nih.gov/30375524/

Increasing smoking intensity is associated with increased disease activity in axial spondyloarthritis (2017)
https://pubmed.ncbi.nlm.nih.gov/27815702/